Artivion | CRY - Biaya Operasional





Biaya Operasional Perubahan Tanggal
Abbott USD 11.66B 1.2B 2026-09
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 150.1M 6.16M 2026-09
Baxter International USD 6.5B 3.82B 2026-09
Becton, Dickinson and Co. USD 4.16B 20.25B 2026-09
Boston Scientific USD 4.13B 72M 2026-09
Edwards Lifesciences USD 10.86B 9.64B 2026-09
Inogen USD 49.14M 665K 2024-09
Integra LifeSciences USD 368.53M 674.84M 2026-09
J&J USD 18.93B 1.09B 2026-09
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Pfizer USD 89B 3.81B 2026-09
ResMed USD 1.01B 83.57M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 286.06M 17.71M 2026-09
Teleflex USD 3.49B 589.18M 2026-09
Terumo JPY 331.37B 109.04B 2026-09
Trinity Biotech USD 12.63M 255K 2026-03